Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Pelvic Organ Prolapse
100%
Vesicovaginal Fistula
88%
Obstetrics and Gynaecology
59%
Risk Factors
58%
Indonesia
56%
Vaginismus
51%
Platelet-rich Plasma
51%
Quality of Life
45%
Urogynecology
44%
Postmenopausal Women
42%
Randomized Controlled Trial
42%
Meta-analysis
42%
West Java Indonesia
40%
Genitourinary Syndrome of Menopause
36%
Vaginal Septum
34%
Quercetin
34%
Remodeling Phase
34%
Anal Sphincter Injury
34%
Rectovaginal Fistula
34%
Uterine Inversion
34%
Freeze-dried Amnion
34%
Fistula
34%
Surabaya
34%
Uterine Prolapse
34%
Dr. Soetomo General Academic Hospital
34%
Collagen Type III
34%
Matrix metalloproteinase-9 (MMP-9)
34%
Obstetrics
32%
Wound Healing Process
28%
Medical Records
27%
Surgical Procedures
27%
Wound Healing
27%
Referral Hospital
25%
Perineal Tear
24%
Post-repair
24%
Pessary
24%
Perineal Rupture
23%
Muscle Tone
22%
Menopausal Hormone Therapy
21%
Dyspareunia
21%
Malignancy
20%
Pelvic Floor Disorders
20%
Cervical Elongation
20%
Developing Countries
20%
Injury Repair
19%
Latex
19%
Silicone
19%
Stress Urinary Incontinence
19%
Older Women
18%
Outpatient Clinic
18%
Medicine and Dentistry
Pelvic Organ Prolapse
100%
Obstetrics
86%
Systematic Review
69%
Internal Anal Sphincter
62%
Gynecology
56%
Vesicovaginal Fistula
54%
Vaginism
51%
Thrombocyte Rich Plasma
51%
Urogynecology
41%
Estrogen
40%
Pelvic Floor
38%
Wound Healing
37%
Rectovaginal Fistula
34%
Uterine Inversion
34%
Gelatinase B
34%
Injection
32%
Quality of Life
31%
Postmenopause
29%
Fistula
28%
Surgical Technique
27%
Pessary
27%
Infection
25%
Perineal Tear
24%
Hysterectomy
24%
Sexual Function
23%
Muscle Tone
22%
Medical Record
21%
Puerperium
20%
Pelvic Floor Dysfunction
20%
Randomized Controlled Trial
20%
Meta-Analysis
20%
Stress Incontinence
20%
Placebo
19%
Case-Control Study
19%
Outpatient
18%
Amnion
17%
Biofeedback
17%
Vaginal Vault Prolapse
17%
Minimally Invasive Procedure
17%
Aerobic Vaginitis
17%
Tissue Structure
17%
Agenesis
17%
Quercetin
17%
Severe Acute Respiratory Syndrome Coronavirus 2
17%
Tissue Inhibitor of Metalloproteinase 1
17%
Fat Pad
17%
Muscle Strength
17%
Synechiae
17%
Short Form 20
17%
Maintenance Therapy
17%